For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230329:nRSc6189Ua&default-theme=true
RNS Number : 6189U SSE PLC 29 March 2023
SSE PLC
Director/PDMR Shareholding
Notification of Transactions of Directors/Persons Discharging Managerial
Responsibilities (PDMRs)
The Company was notified on 28 March 2023 of a dividend reinvestment by a
nominee provider on behalf of Gregor Alexander (Director), pursuant to a
regular standing order instruction.
The table below, made in accordance with the requirements of the EU Market
Abuse Regulation, provides further details on the number of shares purchased
on 13 March 2023.
1 Details of the person(s) discharging managerial responsibilities/person
closely associated with
a) Name(s) Gregor Alexander (Director)
2 Reason for the notification
a) Position/status As noted in 1a) above
b) Initial notification/Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name SSE plc
b) LEI 549300KI75VYLLMSK856
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Identification Ordinary shares of 50 pence each fully paid
code
ISIN: GB0007908733
b) Nature of transaction Shares awarded to Gregor Alexander (Director) in respect of a dividend
reinvestment by a nominee provider.
c) Price(s) and volume(s) Price: GBP £17.19
Volume: 29 Ordinary shares
d) Aggregated information
- Aggregated volume As noted in 4c) above
- Price As noted in 4c) above
e) Date of transaction 13 March 2023
f) Place of transaction London Stock Exchange Main Market XLON
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHSEDSUUEDSESD